Kidney diseases are increasingly common, affecting millions, with many unaware of their condition. About 40% of people with ...

What are called autoimmune diseases can affect just about every part of the body — and tens of millions of people. While most ...

A striking rise in deaths from alcohol-related liver disease (ALD) is disproportionately impacting people without a college ...

A distinct type of immune cells was found in pancreas of type 1 diabetic people; the discovery offers target for early ...

University of Pennsylvania researchers say their findings could potentially lead to the development of a blood test to monitor people at high risk of developing Type 1 diabetes. New research into ...

Resmetirom sustained improvements in liver stiffness and several liver biomarkers among patients with metabolic ...

Findings represent a detailed resource for future research that could lead to the development of new biomarkers and targeted therapeutics for T1D.

Type 1 diabetes (T1D) impacts nearly two million Americans, and by the time most people learn they have it, most of the ...

Type 1 diabetes (T1D) impacts nearly two million Americans, and by the time most people learn they have it, most of the body's insulin-producing cells are destroyed. Now, pinpointing a hidden group of ...

The U.S. Food and Drug Administration is tightening restrictions on a gene therapy used to treat Duchenne muscular dystrophy ...

A gene therapy for Duchenne muscular dystrophy caused complications to the liver, prompting a review of its use for younger patients.

Following the FDA approval of a vagus nerve stimulator for rheumatoid arthritis, supporters of the device’s use have lauded it as a turning point in the field of immuno-autonomics and the treatment of ...